DR. JASBIR SINGH, M.D.
Psychiatric at Washington St, Naperville, IL
License number
Illinois 036063003
Category
Osteopathic Medicine
Type
Anesthesiology
License number
Illinois 036063003
Category
Psychiatric
Type
Interventional Pain Medicine
Address
Address
801 S Washington St, Naperville, IL 60540
Phone
(630) 355-0450
Organization information
See more information about JASBIR SINGH at bizstanding.comJasbir Singh MD
Anesthesiology Dept, Naperville, IL 60540
Industry:
Anesthesiology, Pain Management
Phone:
(630) 527-3000 (Phone)
Jasbir K. Singh
Professional information
Dr. Jasbir Singh, Naperville IL - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
801 S Washington St, Naperville 60540
(630) 348-3300 (Phone)
(630) 348-3300 (Phone)
Certifications:
Anesthesiology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Lala Lajpat Rai Memorial Medical College, Chaudhry Charan Singh University, Meerut
Graduated: 1972
Lala Lajpat Rai Memorial Medical College, Chaudhry Charan Singh University, Meerut
Graduated: 1972
Jasbir K Singh, Naperville IL
Specialties:
Anesthesiology, Interventional Pain Medicine
Work:
Dupage Valley Anesthesiologists, Ltd.
Anesthesiology Dept, Naperville, IL 60540
Anesthesiology Dept, Naperville, IL 60540
Education:
Lala Lajpat Rai Memorial Medical College (1972)
Biaryl Pde4 Inhibitors For Treating Pulmonary And Cardiovascular Disorders
US Patent:
2012021, Aug 23, 2012
Filed:
Apr 27, 2012
Appl. No.:
13/457716
Inventors:
Jasbir SINGH - Naperville IL, US
Mark E. GURNEY - Grand Rapids MI, US
Alex BURGIN - Kingston WA, US
Alexander KISELYOV - San Diego CA, US
Munagala RAO - Westmont IL, US
Timothy HAGEN - Lisle IL, US
Mark E. GURNEY - Grand Rapids MI, US
Alex BURGIN - Kingston WA, US
Alexander KISELYOV - San Diego CA, US
Munagala RAO - Westmont IL, US
Timothy HAGEN - Lisle IL, US
Assignee:
DeCODE Genetics enf - Reykjavik
International Classification:
A61K 31/505, C07D 207/16, C07D 231/12, C07D 213/79, C07C 307/10, C07D 239/42, C07C 69/767, C07D 401/06, A61K 31/522, A61K 31/40, A61K 31/415, A61K 31/4412, A61K 31/165, A61K 31/235, A61K 31/4427, A61K 31/473, A61K 31/4748, A61K 31/445, A61K 31/355, A61K 31/122, A61P 9/00, A61P 9/10, A61P 35/00, A61P 11/06, A61P 11/00, A61P 19/08, A61P 13/10, C07D 473/18
US Classification:
424 941, 544276, 548532, 5483761, 546298, 564 79, 544297, 560 53, 546194, 51426337, 514423, 514406, 514350, 514600, 514275, 514543, 51421018, 51426331, 51426332, 514297, 514295, 514319, 514458, 514690
Abstract:
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id:A particular embodiment is
Aryl Sulfonamide Peri-Substituted Bicyclics For Occlusive Artery Disease
US Patent:
2006014, Jun 29, 2006
Filed:
Oct 11, 2005
Appl. No.:
11/247456
Inventors:
Jasbir Singh - Naperville IL, US
Mark Gurney - Grand Rapids MI, US
Georgeta Hategan - Naperville IL, US
Mark Gurney - Grand Rapids MI, US
Georgeta Hategan - Naperville IL, US
Assignee:
deCODE Chemistry, Inc. - Woodridge IL
International Classification:
C07D 513/02, A61K 31/519, A61K 31/43, A61K 31/4188, A61K 31/4162, A61K 31/401, A61K 31/366
US Classification:
514343000, 514366000, 514406000, 514423000, 514460000, 514548000, 514262100, 548154000, 548302100
Abstract:
Aryl sulfonamide, peri-substituted, fused bicyclic ring compounds useful for the treatment or prophylaxis of a prostaglandin-mediated disease or condition are disclosed. The compounds are of the general formula
A representative example is:
Biaryl Nitrogen-Heterocycle Inhibitors Of Lta4H For Treating Inflammation
US Patent:
7750012, Jul 6, 2010
Filed:
Aug 3, 2006
Appl. No.:
11/462278
Inventors:
Vincent Sandanayaka - Northboro MA, US
Jasbir Singh - Naperville IL, US
Li-Ming Zhou - Hinsdale IL, US
Mark E. Gurney - Grand Rapids MI, US
Jasbir Singh - Naperville IL, US
Li-Ming Zhou - Hinsdale IL, US
Mark E. Gurney - Grand Rapids MI, US
Assignee:
deCODE genetics ehf - Reykjavik
International Classification:
A61K 31/495, A61K 31/496, C07D 295/15, C07D 333/16, A61K 31/5375, A61K 31/5377, A61K 31/451, A61K 31/4523, C07D 211/34, C07D 211/58, C07D 413/12
US Classification:
51425213, 51425503, 5142315, 5142392, 514317, 514329, 514331, 544146, 544174, 544379, 544391, 544394, 546223, 546224, 546239
Abstract:
The present invention relates to a chemical genus of biaryl nitrogen-attached heterocycles that are inhibitors of LTA4H (leukotriene A4 hydrolase). The compounds have the general formula.
Biaryl Pde4 Inhibitors For Treating Pulmonary And Cardiovascular Disorders
US Patent:
2009013, May 28, 2009
Filed:
Nov 20, 2008
Appl. No.:
12/275152
Inventors:
Jasbir Singh - Naperville IL, US
Mark E. Gurney - Grand Rapids MI, US
Alex Burgin - Kingston WA, US
Alexander Kiselyov - San Diego CA, US
Munagala Rao - Westmont IL, US
Timothy Hagen - Lisle IL, US
Mark E. Gurney - Grand Rapids MI, US
Alex Burgin - Kingston WA, US
Alexander Kiselyov - San Diego CA, US
Munagala Rao - Westmont IL, US
Timothy Hagen - Lisle IL, US
Assignee:
DECODE GENETICS EHF - Reykjavik
International Classification:
A61K 31/44, C07D 231/12, C07D 213/64, C07D 239/42, C07D 213/79, C07C 275/28, C07D 285/135, A61K 31/433, A61K 31/4439, A61P 1/00, A61P 11/00, A61P 35/00, A61P 9/00, A61K 31/122, A61K 31/4353, A61K 31/435, A61K 31/4427, A61K 31/437, A61K 31/4545, C07D 401/06, C07D 471/04, C07D 213/72, A61K 31/415, A61K 31/4412, A61K 31/495
US Classification:
424 941, 5483761, 546290, 544297, 546326, 560 43, 548138, 546194, 5462791, 546121, 546306, 514406, 514350, 514275, 514354, 514363, 514318, 514343, 514300, 514357, 51421018, 514297, 514319
Abstract:
The present invention relates to a genus of biaryl compounds containing at least one further ring. The compounds are PDE4 inhibitors useful for the treatment and prevention of stroke, myocardial infarct and cardiovascular inflammatory diseases and disorders. The compounds have general formula Ia, Ib, Ic or Id:A particular embodiment is
Biaryl Substituted Heterocycle Inhibitors Of Lta4H For Treating Inflammation
US Patent:
7402684, Jul 22, 2008
Filed:
Jun 23, 2006
Appl. No.:
11/426287
Inventors:
Vincent Sandanayaka - Northboro MA, US
Jasbir Singh - Naperville IL, US
Mark Gurney - Grand Rapids MI, US
Bjorn Mamat - Reykjavik, IS
Peng Yu - Lisle IL, US
Louis Bedell - Prospect Heights IL, US
Lei Zhao - Naperville IL, US
Rama K. Mishra - Chicago IL, US
Jasbir Singh - Naperville IL, US
Mark Gurney - Grand Rapids MI, US
Bjorn Mamat - Reykjavik, IS
Peng Yu - Lisle IL, US
Louis Bedell - Prospect Heights IL, US
Lei Zhao - Naperville IL, US
Rama K. Mishra - Chicago IL, US
Assignee:
deCODE genectics ehf. - Reykjavik
International Classification:
C07D 207/08, A61K 31/40
US Classification:
548574, 514428
Abstract:
The present invention relates to a chemical genus of biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders. The compounds have general formula Ψ:An example is.
4- (Or 5-) Substituted Catechol Derivatives
US Patent:
2009013, May 21, 2009
Filed:
Nov 20, 2008
Appl. No.:
12/275168
Inventors:
Jasbir Singh - Naperville IL, US
Mark E. Gurney - Grand Rapids MI, US
Alex Burgin - Kingston WA, US
Vincent Sandanayaka - Northboro MA, US
Alexander Kiselyov - San Diego CA, US
Mark E. Gurney - Grand Rapids MI, US
Alex Burgin - Kingston WA, US
Vincent Sandanayaka - Northboro MA, US
Alexander Kiselyov - San Diego CA, US
Assignee:
DECODE GENETICS EHF - Reykjavik
International Classification:
A61K 31/165, C07C 233/02, A61P 29/00
US Classification:
514619, 564188
Abstract:
Compounds of the formula:are disclosed. The compounds act as phosphodiesterase-4 modulators, and useful for treating stroke, myocardial infarct, and cardiovascular inflammatory conditions. Other embodiments are also disclosed.
2,4-Diaminoquinazolines For Spinal Muscular Atrophy
US Patent:
7888366, Feb 15, 2011
Filed:
Jun 7, 2005
Appl. No.:
11/147127
Inventors:
Jasbir Singh - Naperville IL, US
Mark E. Gurney - Grand Rapids MI, US
Mark E. Gurney - Grand Rapids MI, US
Assignee:
Families of Spinal Muscular Atrophy - Libertyville IL
International Classification:
A61K 31/517, C07D 239/95
US Classification:
5142664, 544291
Abstract:
2,4-Diaminoquinazolines of formulae I-IV and VI.
2,4-Diaminoquinazolines For Spinal Muscular Atrophy
US Patent:
7985755, Jul 26, 2011
Filed:
Aug 1, 2007
Appl. No.:
11/832255
Inventors:
Jasbir Singh - Naperville IL, US
Mark E. Gurney - Grand Rapids MI, US
Mark E. Gurney - Grand Rapids MI, US
Assignee:
Families of Spinal Muscular Atrophy - Libertyville IL
International Classification:
A61K 31/517
US Classification:
5142664, 544291, 544359, 546199, 5462681, 548240, 5483351, 548560, 549 59, 549356, 549398, 549505
Abstract:
2,4-Diaminoquinazolines of formula (I).